ShareHope Medicine Co., Ltd.(TW:8403)
NT$18.55+-0.05 (+4.51%)
TW:8403
ShareHope Medicine Co., Ltd. financials statements
NT$18.55
At close:+-0.05 (+4.51%)
ShareHope Medicine Co., Ltd. (8403) Ratios
ShareHope Medicine Co., Ltd. Ratios
TW:8403's free cash flow for Q2 2026 was NT$151.85M. For the 2026 fiscal year, TW:8403's free cash flow was decreased by NT$-11.60M and operating cash flow was NT$163.45M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.00 | 1.82 | 1.65 | 1.85 | 2.14 |
| Quick Ratio | 1.82 | 1.67 | 1.50 | 1.69 | 1.95 |
| Cash Ratio | 0.86 | 0.78 | 0.70 | 0.89 | 1.06 |
| Solvency Ratio | 0.15 | 0.16 | 0.13 | 0.18 | 0.24 |
| Operating Cash Flow Ratio | 0.23 | 0.14 | 0.13 | 0.37 | 0.24 |
| Short-Term Operating Cash Flow Coverage | 0.70 | 0.38 | 0.44 | 1.30 | 0.78 |
| Net Current Asset Value | NT$ 349.02M | NT$ 271.74M | NT$ -250.46M | NT$ -86.28M | NT$ 925.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.28 | 0.29 | 0.29 | 0.21 |
| Debt-to-Equity Ratio | 0.52 | 0.56 | 0.63 | 0.62 | 0.42 |
| Debt-to-Capital Ratio | 0.34 | 0.36 | 0.38 | 0.38 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.19 | 0.22 | 0.22 | 0.04 |
| Financial Leverage Ratio | 1.92 | 2.00 | 2.13 | 2.16 | 1.94 |
| Debt Service Coverage Ratio | 0.55 | 0.65 | 0.68 | 1.11 | 1.07 |
| Interest Coverage Ratio | 1.69 | 3.25 | 2.22 | 9.86 | 13.52 |
| Debt to Market Cap | 0.52 | 0.42 | 0.41 | 0.39 | 0.21 |
| Interest Debt Per Share | 17.00 | 15.79 | 17.72 | 17.01 | 10.54 |
| Net Debt to EBITDA | 1.32 | 1.01 | 1.64 | 0.83 | -0.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 13.17% | 16.51% | 18.75% | 23.78% | 21.66% |
| EBIT Margin | 1.85% | 5.37% | 4.20% | 9.14% | 7.47% |
| EBITDA Margin | 8.01% | 12.48% | 12.52% | 16.56% | 15.39% |
| Operating Profit Margin | 1.85% | 4.38% | 3.07% | 9.09% | 7.07% |
| Pretax Profit Margin | 3.45% | 4.02% | 2.81% | 8.22% | 6.95% |
| Net Profit Margin | 3.25% | 4.63% | 3.22% | 7.11% | 6.04% |
| Continuous Operations Profit Margin | 2.57% | 2.83% | 1.43% | 5.91% | 5.03% |
| Net Income Per EBT | 94.39% | 115.06% | 114.29% | 86.47% | 86.93% |
| EBT Per EBIT | 185.80% | 91.80% | 91.51% | 90.39% | 98.30% |
| Return on Assets (ROA) | 2.14% | 2.82% | 1.67% | 3.98% | 3.81% |
| Return on Equity (ROE) | 4.12% | 5.63% | 3.57% | 8.60% | 7.39% |
| Return on Capital Employed (ROCE) | 1.60% | 3.61% | 2.17% | 6.66% | 5.87% |
| Return on Invested Capital (ROIC) | 1.06% | 2.21% | 0.97% | 4.31% | 3.77% |
| Return on Tangible Assets | 2.25% | 2.95% | 1.75% | 4.18% | 4.03% |
| Earnings Yield | 5.59% | 5.55% | 3.25% | 7.91% | 8.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.56 | 2.77 | 2.65 | 3.14 | 3.10 |
| Payables Turnover | 5.55 | 5.43 | 4.20 | 4.47 | 5.47 |
| Inventory Turnover | 12.97 | 12.36 | 10.61 | 11.57 | 10.38 |
| Fixed Asset Turnover | 2.52 | 2.35 | 1.86 | 1.92 | 3.54 |
| Asset Turnover | 0.66 | 0.61 | 0.52 | 0.56 | 0.63 |
| Working Capital Turnover Ratio | 2.81 | 3.08 | 2.83 | 2.63 | 2.40 |
| Cash Conversion Cycle | 64.81 | 93.89 | 85.31 | 66.22 | 86.10 |
| Days of Sales Outstanding | 102.42 | 131.60 | 137.81 | 116.27 | 117.66 |
| Days of Inventory Outstanding | 28.15 | 29.54 | 34.39 | 31.55 | 35.17 |
| Days of Payables Outstanding | 65.76 | 67.25 | 86.89 | 81.60 | 66.74 |
| Operating Cycle | 130.57 | 161.14 | 172.20 | 147.82 | 152.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.35 | 2.04 | 2.04 | 5.10 | 2.86 |
| Free Cash Flow Per Share | 2.14 | 1.33 | -0.16 | -5.09 | 1.65 |
| Dividend Paid and CapEx Coverage Ratio | 1.82 | 1.82 | 0.76 | 0.48 | 1.41 |
| Capital Expenditure Coverage Ratio | 2.76 | 2.87 | 0.93 | 0.50 | 2.37 |
| Operating Cash Flow Coverage Ratio | 0.20 | 0.13 | 0.12 | 0.31 | 0.28 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.06 | 0.07 | 0.16 | 0.09 |
| Free Cash Flow Yield | 9.16% | 4.82% | -0.52% | -17.27% | 7.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 22.67 | 18.02 | 30.71 | 12.65 | 12.12 |
| Price-to-Sales (P/S) Ratio | 0.58 | 0.83 | 0.99 | 0.90 | 0.73 |
| Price-to-Book (P/B) Ratio | 0.74 | 1.01 | 1.10 | 1.09 | 0.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.92 | 20.76 | -190.90 | -5.79 | 13.60 |
| Price-to-Operating Cash Flow Ratio | 6.97 | 13.52 | 14.90 | 5.78 | 7.85 |
| Price-to-Earnings Growth (PEG) Ratio | -0.69 | 0.33 | -0.53 | 0.49 | -1.85 |
| Enterprise Value Multiple | 8.58 | 7.69 | 9.54 | 6.26 | 4.35 |
| Enterprise Value | 3.00B | 4.15B | 4.63B | 4.29B | 2.58B |
| EV to EBITDA | 8.58 | 7.69 | 9.54 | 6.26 | 4.35 |
| EV to Sales | 0.69 | 0.96 | 1.20 | 1.04 | 0.67 |
| EV to Free Cash Flow | 12.90 | 23.92 | -230.61 | -6.68 | 12.40 |
| EV to Operating Cash Flow | 8.23 | 15.57 | 18.00 | 6.67 | 7.16 |
| Tangible Book Value Per Share | 32.42 | 27.98 | 28.71 | 29.80 | 28.13 |
| Shareholders’ Equity Per Share | 31.70 | 27.20 | 27.67 | 27.13 | 24.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.30 | 0.49 | 0.28 | 0.28 |
| Revenue Per Share | 40.11 | 33.08 | 30.73 | 32.82 | 30.55 |
| Net Income Per Share | 1.30 | 1.53 | 0.99 | 2.33 | 1.85 |
| Tax Burden | 0.94 | 1.15 | 1.14 | 0.86 | 0.87 |
| Interest Burden | 1.86 | 0.75 | 0.67 | 0.90 | 0.93 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.14 | 0.17 | 0.18 | 0.17 | 0.17 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.43 | 1.53 | 2.36 | 2.19 | 1.55 |
Currency in TWD
